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© 2011 Japanese Society of Tropical Medicine Abstract: Lead-containing cooking utensils, sometimes used in South Indian homes, and indigenous medications,
widely used in India and increasingly in developed countries, may be responsible for lead intoxication in adults.
We report chronic lead poisoning in five adult patients. Not all patients had abdominal colic, while dramatic
weight loss, depression and encephalopathy were seen. Once recognized, lead poisoning is treatable and some-
times preventable. Response to chelation therapy with agents such as calcium ethylenediaminetetraacetate
(CaEDTA) is impressive, although several courses of therapy may be necessary.
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INTRODUCTION
Lead poisoning has been known since ancient times
[1] and is recognized worldwide in adults and in children
[2–4]. Stringent regulations regarding the use of lead-based
compounds has decreased the incidence of lead poisoning in
developed nations. This is not the case in the developing
world. Additionally, folk medicine, Ayurvedic and Homeo-
pathic remedies, largely unregulated, are widely used in de-
veloping countries. Also unregulated is the manufacturing
process of these medications which may be contaminated
by heavy metals. This report serves to remind one that lead
poisoning remains a problem in certain tropical and devel-
oping countries. Once recognized, however, it is a condition
that can be effectively treated and sometimes prevented
from recurring.
The symptoms and signs of lead poisoning are not
pathognomonic and are commonly encountered in other
diseases. Chronic lead poisoning can manifest clinically in
one of three forms: (1) the alimentary form characterized by
anorexia, vomiting, a metallic taste, constipation or diar-
rhoea, colicky abdominal pain (lead colic) or abdominal
wall rigidity. (2) The neuromuscular form, which is more
commonly seen in adults, presents with muscle weakness,
myalgias, arthralgias, wrist drop, peripheral neuritis, muscle
atrophy, weakness and tremor of forearm extensors. (3) The
cerebral or the neuropsychiatric form, more commonly seen
in children, is characterized by irritability, sleeplessness, en-
cephalopathy, headache, dizziness, memory problems, con-
fusion, loss of vision and convulsions [5–11]. Less com-
monly, chronic renal disease and toxic hepatitis can be seen
in lead poisoning, possibly a result of contaminants rather
than lead.
Acute lead poisoning is uncommon and is usually due
to a suicide attempt [12], or self-ingestion [13], by mentally
impaired patients in nursing homes and psychiatric facilities
[14]. If ingestion is recognized early and treatment insti-
tuted promptly, the patient may remain asymptomatic.
Acute toxicity may affect several organ systems including
the kidneys, gastrointestinal tract, the central nervous sys-
tem, liver, and the hematopoietic system, resulting in ab-
dominal pain, diarrhoea, vomiting, haemolytic anaemia,
hepatitis, and minor neurologic dysfunction [14, 15]. Less
commonly delirium and hallucinations [16], acute renal
failure or death may occur [17].
RESULTS
We report five adult patients to illustrate some uncom-
mon clinical features of lead poisoning and highlight some
unusual sources of lead. The latter are peculiar to some trop-
ical developing countries. However, with the increasing
popularity of complementary and alternative medicine ther-
apy in the West, one must be aware of the possibility of lead
poisoning due to lead contaminated medications.
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Case 1:
A 33-year-old previously healthy housewife presented
with a history of abdominal pain, anorexia, undocumented
weight-loss, constipation, insomnia unrelated to abdominal
pain, and generalized myalgias of one year’s duration. The
abdominal pain usually occurred following a large meal but
at times no obvious precipitating factor was identified. The
pain was boring in nature, persisting for several hours.
Colicky pain was not present at any time. Examination re-
vealed that she was pale, emaciated and depressed. A gingival
lead line was present but no other abnormality was detected.
Investigations revealed a haemoglobin of 11.8 gm%,
haematocrit of 36% and reticulocyte count 7%. The
anaemia was microcytic, hypochromic with basophilic stip-
pling observed in the peripheral blood smear. The total and
differential white blood cell count and platelet count were
normal. The sedimentation rate was 55 mm in the first hour.
Heinz bodies were absent and RBC osmotic fragility, and
Coombs test were negative. Serum liver enzymes and bil-
irubin were normal. Qualitative urinary coproporphyrin and
uroporphyrin were strongly positive. The blood lead level
was 150 μg/dl and 24-hour urinary lead was 240 μg.
A diagnosis of lead poisoning was made and the pa-
tient was treated with CaEDTA 1 gm in 200 ml 5% dex-
trose, twice daily intravenously for five days. The blood
lead level decreased to 75 μg/dl, urinary porphyrins became
negative, the reticulocyte count fell to 1% and the patient
became asymptomatic. The source of lead poisoning could
not be determined.
A year later she presented with severe generalized
colicky abdominal pain, vomiting and weakness. On exam-
ination, she was found to be rolling in bed secondary to
colicky abdominal pain. No other abnormality on physical
examination was noted. Results of investigations were as
follows: haemoglobin of 8.5 gm%, a haematocrit of 28%,
reticulocyte count 7% and a normal total and differential
white blood cell count. Plain films of the abdomen were
normal. Qualitative urinary coproporphyrin was strongly
positive and blood lead levels elevated. CaEDTA was given
as before following which the symptoms subsided com-
pletely. The haemoglobin rose to 11.1 gm%, the haematocrit
to 31% and urinary coproporphyrins became undetectable
two weeks following therapy. She was asymptomatic at
follow-up seven months later although she had a reticulo-
cyte count of 5%.
Despite a detailed history the source of lead could not
be identified. She was not using any lead-glazed earthen-
ware vessels at home for storing foods or water, nor was she
taking any indigenous medications. The lead content of the
drinking water was not elevated. Lead containing fuel or
gasoline is no longer available.
Case 2:
A 30-year-old male healthy office worker, complained
of constant noncolicky lower abdominal pain and backache
of one month’s duration. He had unintentionally lost 13.5 kg
during this time. He gave no history of abdominal colic,
constipation or vomiting. He was pale and a gingival lead
line was present. The rest of his examination was otherwise
unremarkable.
Investigations revealed a haemoglobin of 10.6 gm%,
haematocrit 30% and a reticulocyte count of 18%. The
anaemia was hypochromic and microcytic with faint
basophilic stippling in the peripheral blood smear. Urine
corproporphyrins was strongly positive. Bone marrow ex-
amination showed normoblastic maturation with erythroid
hyperplasia and basophilic stippling. Serum liver enzymes,
bilirubin and albumin and a plain film of the abdomen were
normal. Treatment with CaEDTA 500 mg in 5% dextrose
intravenously for 5 days resulted in marked improvement in
symptoms and sense of well being. The haematocrit rose to
37% and the urinary coproporphyrins were negative.
A month later he was readmitted because of lower
abdominal colicky pain. He had gained 2 kg. Investigations
revealed a haematocrit of 38% and reticulocyte count of
0.5%. The urinary coproporphyrin was again strongly
positive.
Following CaEDTA re-administration the abdominal
pain completely subsided and he gained 4 kg over a period
of one month. The source of lead was identified to be a lead-
lined utensil which had been procured 3 months earlier and
was being used to cook a popular South Indian food pre-
paration called ‘rasam’ (an infusion of tamarind and pepper
water). No other member of his family showed clinical or
biochemical evidence of lead poisoning.
Case 3:
A 45-year-old male hotel owner with no known medi-
cal problems complained of constant, mild, epigastric pain,
nonradiating in nature, episodic bilious vomiting half an
hour after food and constipation, all of 15 days’ duration.
The pain was not relieved by vomiting or over-the-counter
antacids. While undergoing evaluation, he developed
features of depression and a few days later he became con-
fused. His brother had died two years earlier in another hos-
pital with similar symptoms. On physical examination, he
was pale and confused with no other significant clinical
findings. In particular, there was no localizing neurologic
finding including neck rigidity.
Investigations confirmed that he was anaemic with a
haemoglobin of 9.5 gm%, haematocrit of 29%. The reticu-
locyte count was 8.5%. No basophilic stippling was de-
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in the first hour was 57 mm, Coombs test was negative.
Serum liver enzymes and bilirubin were normal. Qualitative
urinary coproporphyrin was strongly positive and porpho-
bilinogen was negative. A 24 hour urinary lead excretion
was 530 μg and blood lead levels 290 μg%.
CaEDTA 1 gm was administered intravenously in 200
ml of 5% glucose for 10 days. After the first dose of EDTA
the 24-hour urine lead level increased to 1,395 μg and on
the second day to 2,090 μg. At the time of discharge, the
patient was no longer confused and he felt well.
Ten days later he was readmitted because of mild par-
esthesias in the lower limbs. An electromyogram suggested
mixed motor and sensory neuropathy. The haematocrit was
37% and the reticulocyte count 5%. The 24-hour urine lead
excretion was 225 μg. Therapy with CaEDTA was reinsti-
tuted following which the 24-hour urinary lead was 3,946
μg. At the time of discharge the haematocrit was 42%, the
reticulocyte count 2%, and the patient was asymptomatic.
No source of lead could be identified and the patient was
lost to follow-up.
Case 4:
A 51-year-old male accountant presented with a
history of constipation, anorexia, and unintentional, docu-
mented weight loss of 18 kg in one month. He had no ab-
dominal pain. He was a known diabetic and was on regular
treatment with insulin and oral hypoglycaemic agents. He
gave a history of having recovered from viral hepatitis four
months earlier, following which he had begun taking an in-
digenous medicinal powder touted to alleviate weakness.
On physical examination, he was emaciated, pale and eden-
tulous. No other abnormality on examination was detected.
Other members in the family who were asymptomatic were
also examined and found to be clinically normal.
The patient’s haemoglobin was 9.8 gm%, haematocrit
28%, reticulocyte 6.8%. Basophilic stippling was present in
a peripheral blood smear. The blood lead level was 90 μg%.
Liver enzymes and bilirubin were normal. The sedimenta-
tion rate was 45 mm in the first hour. Qualitative urinary co-
proporphyrin was strongly positive. Chemical analysis of
the indigenous medicinal powder revealed the presence of
lead carbonate.
CaEDTA 1 gm was given intravenously daily for 5
days following which the patient’s appetite improved and
his bowel habits returned to normal. At follow-up 3 months
later he felt well and had gained 10 kg. His haemoglobin was
13.6 gm%, haematocrit 41%, and the reticulocyte 1.5%.
Case 5:
A 24-year-old previously healthy male student pre-
sented with constant mild left lower quadrant pain of one
week’s duration. He had had three episodes of generalized
colicky abdominal pain during the previous six months,
lasting for 1–2 hours. Unlike the previous episodes, the
present one did not respond to antispasmodics. There was
no history of constipation, anorexia, weight loss, vomiting
or gastrointestinal haemorrhage. On physical examination
he was a moderately built young man. He had ill-defined
tenderness over the left iliac fossa and no other abnormality.
The haemoglobin was 10.3 gm%, haematocrit 34%,
and reticulocyte count 8.8%. Red cells were hypochromic,
microcytic with basophilic stippling present on the periph-
eral blood smear. The bone marrow was hypocellular with
normal erythroid hyperplasia, increased polychromasia and
occasional basophilic stippling. The platelet count was
280,000 per cu/mm
3. The sedimentation rate was 10 mm in
the first hour. Serum iron, folate, calcium and phosphorus
levels were normal. Coombs test was negative and serum
liver enzymes were normal. Urine for coproporphyrin and
porphobilinogen were negative. Blood lead was 110 μg%
and 24-hour urine lead 463 μg. Following therapy with
parenteral CaEDTA 500 mg twice a day intravenously in
500 ml of 5% glucose and penicillamine 250 mg four times
a day for four weeks, the haemoglobin rose to 13.2 gm%.
The peripheral smear showed no basophilic stippling and
the blood lead level had fallen to 30 μg%. His 24-hour urine
lead excretion was 5,168 μg. At follow up two months later
he was asymptomatic.
On questioning he said that a new cooking utensil had
recently been acquired and was used exclusively for cook-
ing ‘rasam’. The patient consumed about 150–200 ml of
rasam daily. This was considerably more than the amount
taken by the other three members of the household. His ab-
dominal symptoms began 3 months after the family started
using this vessel for cooking. A sample of rasam prepared in
the usual way by the family was found to contain 200 μg%
lead. The other three members of his family were asymp-
tomatic and had no clinical evidence of lead intoxication.
However, some of their laboratory studies were abnormal as
outlined below:
1 The patient’s mother: Haematocrit 46%, reticulocyte
count 6%. Blood lead level 25 μg%.
2 The patient’s brother: Haematocrit 34%, reticulocyte
count 4.5%, blood picture showed no basophilic stippling
and the blood lead level was 95 μg%.
3 The patient’s younger brother: Haematocrit 39%, reticu-
locyte count 4.5%, and blood picture did not show baso-
philic stippling and blood lead level 50 μg%.
DISCUSSION
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recognized by the classic ‘lead colic’ [18] which is believed
to be due to intestinal spasms. The aetiology of the intestinal
spasms remains conjectural. It has been suggested that lead
competes for transport with calcium and other divalent cat-
ions such as magnesium and zinc. This, in turn, interferes
with mitochondrial oxidative phosphorylation and intracel-
lular signalling processes which affects intestinal motility
[19]. The five patients in this report highlight the fact that
colicky abdominal pain is not always present, that the pain
can be situated over any part of the abdomen and can vary
considerably in severity (Case 1 and 3). The uncharacteris-
tic nature of the abdominal pain can delay arriving at the
right diagnosis as one pursues the investigation for other
conditions associated with abdominal pain, such as pancre-
atitis and renal colic. Additionally, abdominal pain may be
the result of lead affecting the visceral autonomic nervous
system or lead-induced interstitial pancreatitis [20]. It is
generally believed that abdominal colic and pain may occur
when blood levels are greater than 40 μg% and is present
when levels are greater than 80 μg%. This is not always so
as illustrated by the brothers of Case 5 who had blood levels
of 50 and 95 μg/dl respectively but were asymptomatic.
Blood lead levels reflect recent rather than cumulative
absorption since approximately 90% of absorbed lead is
deposited in soft tissue and the skeleton [21]. The nutri-
tional status of the individual can influence an individual’s
response to a toxic substance. Hypocalcaemia, iron defi-
ciency and deficiency of trace metals such as zinc and cop-
per may exacerbate the toxic effects of lead. We did not
measure circulating trace metal levels in our patients. The
composition of an individual’s diet may also play a role in
the response to lead exposure [4, 22]. These factors may ex-
plain variations in the degree of lead poisoning seen in indi-
viduals with similar lead exposure as evidenced by the fact
that family members of Cases 2 and 5 remained asymptom-
atic despite some of them having high lead levels. The sug-
gestion that there is a correlation between the blood lead
concentrations of the index case and blood lead levels of
other household members [23] is not borne out in the one
family (Case 5) where we had an opportunity to study other
family members. It is also possible that individuals may
have a genetic susceptibility to lead poisoning [24]. Ethnic
and environmental factors may also play a role.
On a peripheral blood smear, the anemia of lead poi-
soning is typically microcytic and hypochromic. Basophilic
stippling is not specific for lead poisoning and has been
reported in other conditions including pyrimidine nucleoti-
dase deficiency, B12 deficiency and thalassemia.
The cases reported illustrate the fact that lead poison-
ing may present with misleading symptoms. In our patients
it prompted investigation for a diagnosis of a depressive ill-
ness (Case 1, insomnia, abdominal pain and anorexia), co-
lonic malignancy (Case 4, constipation of recent onset and
marked weight loss). It can also present with symptoms
which are not typical of any illness (Case 5). Case 3 serves
to reinforce previously published reports that neuropsychi-
atric manifestations and encephalopathy, although more fre-
quently reported in the paediatric literature [4], can also
occur in adults. Weight loss in patients with lead poisoning
has been reported but its aetiology remains unclear.
The sources of lead reported to be implicated in lead
poisoning are numerous and include contaminated water
[25], soil, glazed pottery which gives up lead in large quan-
tities to food such as pickles and sour fruits and is possibly
related to the acid medium [14], lead contaminated foods,
inhalation of lead fumes, paint and illicit alcohol beverages.
Cases 2 and 5 emphasize that cooking utensils can be a
source of lead. Lead poisoning as a result of lead contami-
nated folk remedy has been reported previously [18]. We
were able to demonstrate a high lead content in the indige-
nous medicinal powder that Case 4 had been taking as a
general tonic. Folk medicine is still used extensively in
India, and increasingly in other parts of the world. This may
be due to a variety of reasons including the high cost of pre-
scription medications, restricted physician access and re-
ports of unwanted side effects of prescription medication
[26]. Additionally, there appears to be the innate, albeit mis-
taken, belief that botanical products, being ‘natural,’ are
safe. No home visits were made to identify the source of
lead in Cases 1 and 3 in whom no obvious source of lead
was found.
In recent years some folk remedies and Ayurvedic
medications have been shown to be contaminated with
heavy metals, including lead [18, 27, 28] and their use has
resulted in toxicity. 14 of 70 Ayurvedic herbal medicinal
products sold in South Asian grocery stores in Boston had
potentially harmful levels of lead, mercury and/or arsenic
[28]. Additionally, there are well-documented instances of
lead toxicity due to herbal medication ingestion [18, 27,
29]. There is little data on the chemical composition of these
powders and little is known of lead blood levels in the com-
munity. It may be that some patients diagnosed with non-
ulcer dyspepsia or abdominal pain of unknown origin are, in
fact, patients with lead poisoning.
Our report confirms the efficacy of the chelating agent
CaEDTA in the treatment of lead poisoning. It also empha-
sizes the fact that symptomatic recurrences are an ever-
present danger because circulating lead that gets rapidly de-
posited in the skeletal system [30] is excreted very slowly,
making bones act as a reservoir from which lead re-enters
the circulation leading to relapses (Case 1). More recently,
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effective alternative to CaEDTA and D-penicillamine is a
useful agent to mobilize stored lead once the patient is
asymptomatic.
Identifying the source of lead in patients with lead tox-
icity and avoiding further exposure are the only definitive
measures for preventing further lead poisoning. However,
as in two of our patients, identifying the source of lead is not
always easy and in such situations regular follow up of
blood lead levels and treatment with a chelating agent when
indicated is appropriate.
We report these cases to remind practitioners in
tropical and less well-developed countries to keep lead-
poisoning in mind when confronted with symptoms such as
those experienced by our patients, and to be aware of the
possibility of lead poisoning from their environment.
Patients are unlikely to volunteer pertinent history and, if
this diagnosis is not borne in mind, a preventable and treat-
able condition can have fatal consequences.
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